**Specifications Table**TableSubject areaBiologyMore specific subject areaInfectious diseasesType of dataRaw fastq files, Excel tables and figuresHow data was acquiredIllumina MiSeqData formatRaw and analysed dataExperimental factorsExtra pulmonary isolates from cerebrospinal fluid (CSF), joint aspirate pus and fine needle aspiration cytology were cultured on LJ slants and genomic DNA was isolated using cetyltrimethylammonium bromide (CTAB) methodExperimental featuresLibrary preparation and sequencing was performed according to Illumina Miseq specific protocolsData source locationPunjab and Bangalore, IndiaData accessibilityData is with this article and whole genome sequencing data is available in NCBI SRA database with accession PRJNA358480, <https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA358480>.<https://www.ncbi.nlm.nih.gov/sra/SRX2439868><https://www.ncbi.nlm.nih.gov/sra/SRX2439869><https://www.ncbi.nlm.nih.gov/sra/SRX2439870><https://www.ncbi.nlm.nih.gov/sra/SRX2439871><https://www.ncbi.nlm.nih.gov/sra/SRX2439872>Related research articleWhole genome sequencing of *Mycobacterium tuberculosis* isolates from extrapulmonary sites [@bib1].

**Value of the data**•This data provides insight into the genomic profiles of *M. tuberculosis* clinical isolates from extra pulmonary sites•Lineage-specific SNVs identified in whole genome sequencing allows accurate strain typing and provided the information of lineage distribution of EPTB isolates•The data also provided information on SNVs associated with conferring resistance to anti-tubercular drugs•Since genomic profiles of EPTB isolates remains largely unexplored, this data would add value to our current knowledge on genomes of *M. tuberculosis* isolated from different infection sites

1. Data {#s0005}
=======

The data represents whole genome sequencing of 5 extra pulmonary isolates from 3 different sites. All five clinical isolates sequenced in this data set belonged to East-African-Indian lineage (Lineage 3) ([Fig. 1](#f0005){ref-type="fig"}A). A scientific interpretation of this data set was performed by Sharma et al. [@bib1]. Data analysis led to the identification of 15 SNVs in the coding region of genes ([Fig. 1](#f0005){ref-type="fig"}B), which are known to confer drug resistance to first and second line anti-tubercular drugs ([Supplementary Table 1](#s0045){ref-type="sec"}A). Apart from known drug resistance SNVs, we also identified 199 SNVs in the promoter regions corresponding to 157 genes ([Supplementary Table 1B](#s0045){ref-type="sec"}**) (**[Fig. 2](#f0010){ref-type="fig"}**).** Three of these 157 genes are associated with drug resistance show promoter region SNVs in all of the 5 isolates ([Fig. 1](#f0005){ref-type="fig"}B).Fig. 1**(A)** Phylogenetic tree of five EPTB clinical isolates. **(B)** Distribution of SNVs in the coding and promoter region of genes associated with drug resistance in the five EPTB isolates.Fig. 1Fig. 2Circos plot depicting the promoter region SNVs identified in the study.Fig. 2

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Culturing and DNA isolation of extrapulmonary isolates {#s0015}
-----------------------------------------------------------

The 5 EPTB isolates were obtained from Department of Medical Microbiology, The Postgraduate Institute of Medical Education and Research, Chandigarh, India. The isolates were cultured and maintained as described in [@bib1]. The LJ slants were incubated at 37 °C for a maximum period of 8 weeks. They were inspected daily for growth or for contamination. The isolates were then tested to rule out non tuberculous mycobacteria (NTM) or other infection and were cultured for DNA extraction as previously described [@bib1]. DNA was extracted from the isolates cultured on the LJ slants using cetyltrimethylammonium bromide (CTAB) protocol [@bib2].

2.2. Library preparation and sequencing {#s0020}
---------------------------------------

DNA libraries were constructed and sequencing was carried out on Illumina MiSeq instrument as described previously [@bib1]. Sequencing was performed using a 2 ×100 paired-end (PE) configuration ([Table 1](#t0005){ref-type="table"}).Table 1Raw data statistics.Table 1PlatformIllumina MiSeq (2\*100) paired end**Sample IDCategoryR1R2Total Reads**PGI-14Cerebrospinal fluid(CSF)2,532,2742,532,2745,064,548PGI-98Joint aspirate pus2,250,2032,250,2034,500,406PGI-100Fine needle aspiration cytology (cervical lymph node)2,088,3872,088,3874,176,774PGI-103Fine needle aspiration cytology (cervical lymph node)2,315,9462,315,9464,631,892PGI-155Fine needle aspiration cytology (cervical lymph node)2,454,7732,454,7734,909,546

2.3. Variant calling and data analysis {#s0025}
--------------------------------------

Paired end reads were quality checked using FastQC version-0.11.5. Raw reads of Phred quality score of \< 20 were discarded. High quality reads were mapped to the H37Rv reference genome (NC_000962.3) using Burrows-Wheeler Alignment Tool (BWA version-0.7.15) [@bib3]. Variants were identified using GATK [@bib4]. The variants were annotated using in-house perl scripts. Phylogenetic analysis was carried out using KvarQ version-0.12.2 [@bib5]. SNVs identified in the isolates were used to generate phylogenetic tree FastTree version-2.1.10 [@bib6].

Transparency document. Supplementary material {#s0035}
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Supplementary material

Appendix A. Supplementary material {#s0045}
==================================

**Supplementary Table 1A:** List of SNVs known to confer resistance to first and second line drugs. **Supplementary Table 1B**: List of SNVs identified in the promoter region. Supplementary material
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